These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

452 related items for PubMed ID: 18664341

  • 1. Defining the role of incretin mimetic therapy in the management of type 2 diabetes.
    Unger J, Nadeau DA.
    J Fam Pract; 2007 Dec; 56(12 Suppl New):S4-S10. PubMed ID: 18664341
    [Abstract] [Full Text] [Related]

  • 2. Initiating insulin in patients with type 2 diabetes.
    Aoki TJ, White RD.
    J Fam Pract; 2007 Aug; 56(8 Suppl Hot Topics):S12-20. PubMed ID: 18667139
    [Abstract] [Full Text] [Related]

  • 3. Clinical application of incretin-based therapy: therapeutic potential, patient selection and clinical use.
    Kendall DM, Cuddihy RM, Bergenstal RM.
    Eur J Intern Med; 2009 Jul; 20 Suppl 2():S329-39. PubMed ID: 19580952
    [Abstract] [Full Text] [Related]

  • 4. Natural history of cardiovascular disease in patients with diabetes: role of hyperglycemia.
    Milicevic Z, Raz I, Beattie SD, Campaigne BN, Sarwat S, Gromniak E, Kowalska I, Galic E, Tan M, Hanefeld M.
    Diabetes Care; 2008 Feb; 31 Suppl 2():S155-60. PubMed ID: 18227478
    [Abstract] [Full Text] [Related]

  • 5. Incretin therapy for type 2 diabetes mellitus.
    Klonoff DC.
    Adv Ther; 2010 Dec; 27(12):881-94. PubMed ID: 20978879
    [Abstract] [Full Text] [Related]

  • 6. Effect of blood glucose concentrations on the development of chronic complications of diabetes mellitus.
    Swidan SZ, Montgomery PA.
    Pharmacotherapy; 1998 Dec; 18(5):961-72. PubMed ID: 9758308
    [Abstract] [Full Text] [Related]

  • 7. Targeting the incretin system in type 2 diabetes mellitus.
    Potenza M, Rayfield EJ.
    Mt Sinai J Med; 2009 Jun; 76(3):244-56. PubMed ID: 19421968
    [Abstract] [Full Text] [Related]

  • 8. [Postprandial hyperglycemia. Cardiovascular risks and new therapeutic strategies].
    Sjöholm A.
    Lakartidningen; 2001 Feb 28; 98(9):937-40. PubMed ID: 11292972
    [Abstract] [Full Text] [Related]

  • 9. Clinical application of incretin-based therapy: therapeutic potential, patient selection and clinical use.
    Kendall DM, Cuddihy RM, Bergenstal RM.
    Am J Med; 2009 Jun 28; 122(6 Suppl):S37-50. PubMed ID: 19464427
    [Abstract] [Full Text] [Related]

  • 10. Glycemic control and complications in type 2 diabetes mellitus.
    Stolar M.
    Am J Med; 2010 Mar 28; 123(3 Suppl):S3-11. PubMed ID: 20206730
    [Abstract] [Full Text] [Related]

  • 11. Exploring the pharmacotherapeutic options for treating type 2 diabetes.
    Kruger DF.
    Diabetes Educ; 2008 Mar 28; 34 Suppl 3():60S-65S. PubMed ID: 18525066
    [Abstract] [Full Text] [Related]

  • 12. Managing hyperglycemia in patients with type 2 diabetes mellitus: rationale for the use of dipeptidyl peptidase-4 inhibitors in combination with other oral antidiabetic drugs.
    Freeman JS.
    J Am Osteopath Assoc; 2010 Sep 28; 110(9):528-37. PubMed ID: 20876838
    [Abstract] [Full Text] [Related]

  • 13. Effects of the combination of dipeptidyl peptidase-IV inhibitor ASP8497 and antidiabetic drugs in streptozotocin-nicotinamide-induced mildly diabetic mice.
    Tahara A, Matsuyama-Yokono A, Nakano R, Someya Y, Hayakawa M, Shibasaki M.
    Eur J Pharmacol; 2009 Mar 01; 605(1-3):170-6. PubMed ID: 19171131
    [Abstract] [Full Text] [Related]

  • 14. Incretin-based therapies: review of the outpatient literature with implications for use in the hospital and after discharge.
    Bode B, Amin A.
    Hosp Pract (1995); 2009 Dec 01; 37(1):7-21. PubMed ID: 20720383
    [Abstract] [Full Text] [Related]

  • 15. Mealtime glucose regulation in type 2 diabetes.
    Tuomilehto J, Del Prato S.
    Int J Clin Pract; 2001 Dec 01; 55(6):380-3. PubMed ID: 11501227
    [Abstract] [Full Text] [Related]

  • 16. Incretin-based therapies in type 2 diabetes: a review of clinical results.
    Bosi E, Lucotti P, Setola E, Monti L, Piatti PM.
    Diabetes Res Clin Pract; 2008 Dec 15; 82 Suppl 2():S102-7. PubMed ID: 19022515
    [Abstract] [Full Text] [Related]

  • 17. Insulin strategies for managing inpatient and outpatient hyperglycemia and diabetes.
    Moghissi ES.
    Mt Sinai J Med; 2008 Dec 01; 75(6):558-66. PubMed ID: 19021195
    [Abstract] [Full Text] [Related]

  • 18. Acute glucose fluctuations and chronic sustained hyperglycemia as risk factors for cardiovascular diseases in patients with type 2 diabetes.
    Colette C, Monnier L.
    Horm Metab Res; 2007 Sep 01; 39(9):683-6. PubMed ID: 17846977
    [Abstract] [Full Text] [Related]

  • 19. From hyperglycemia to the risk of cardiovascular disease.
    Leiter LA.
    Rev Cardiovasc Med; 2006 Sep 01; 7 Suppl 2():S3-9. PubMed ID: 17224875
    [Abstract] [Full Text] [Related]

  • 20. Clinical decision making: managing postprandial hyperglycemia.
    Hurel SJ, Mohan V.
    J Assoc Physicians India; 2006 Nov 01; 54():871-6. PubMed ID: 17249256
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.